|
ZNF75A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.998200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.008800E-01 |
| Normal-vs-Stage2 |
3.138400E-01 |
| Normal-vs-Stage3 |
3.525800E-01 |
| Normal-vs-Stage4 |
5.155200E-01 |
| Stage1-vs-Stage2 |
7.328000E-01 |
| Stage1-vs-Stage3 |
1.034840E-01 |
| Stage1-vs-Stage4 |
9.069200E-01 |
| Stage2-vs-Stage3 |
1.468770E-01 |
| Stage2-vs-Stage4 |
9.118200E-01 |
| Stage3-vs-Stage4 |
2.949400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.441000E-01 |
| Normal-vs-AfricanAmerican |
8.305200E-01 |
| Normal-vs-Asian |
5.603400E-01 |
| Caucasian-vs-AfricanAmerican |
8.714400E-01 |
| Caucasian-vs-Asian |
6.082600E-01 |
| AfricanAmerican-vs-Asian |
6.259800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.129000E-01 |
| Normal-vs-Female |
9.994200E-01 |
| Male-vs-Female |
6.448000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.617010E-01 |
| Normal-vs-Extreme_Weight |
5.418400E-01 |
| Normal-vs-Obese |
6.013200E-01 |
| Normal-vs-Extreme_Obese |
3.270600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.496600E-01 |
| Normal_Weight-vs-Obese |
1.050180E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.804000E-01 |
| Extreme_Weight-vs-Obese |
2.906600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.903200E-01 |
| Obese-vs-Extreme_Obese |
2.236600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.513650E-01 |
| Normal-vs-Age(41-60Yrs) |
2.877800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.495600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.567700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.188800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.218030E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.555610E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.199200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.705500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.508000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.385800E-01 |
| Normal-VS-Type2 PRCC |
5.964000E-03 |
| Normal-VS-KIRP CIMP |
6.768400E-02 |
| Normal-VS-Unclassified PRCC |
8.249800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.648100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.009900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.601200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.438700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.183500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.540200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.117600E-02 |
| Normal-vs-N1 |
4.622200E-02 |
| Normal-vs-N2 |
1.290350E-02 |
| N0-vs-N1 |
5.043100E-03 |
| N0-vs-N2 |
1.961760E-01 |
| N1-vs-N2 |
6.332500E-02 |
|
|
